Orenthial J. Fulbright

Statistics

Publications

Citations

793

H-Index

Active since

2010

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Orenthial J. Fulbright is an author at The University of Texas MD Anderson Cancer Center specializing in immunology, immunotherapy, and cancer immunotherapy.

ORCID

Publications per year

2010–2018

Publications

Specific Lymphocyte Subsets Predict Response to Adoptive Cell Therapy Using Expanded Autologous Tumor-Infiltrating Lymphocytes in Metastatic Melanoma Patients

Laszlo Radvanyi, Chantale Bernatchez, Minying Zhang et al. · Clinical Cancer Research · 2012 · 433 citations · Full text

Medicine, Immunology, Oncology +17

Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome

Marie‐Andrée Forget, Cara Haymaker, Kenneth R. Hess et al. · Clinical Cancer Research · 2018 · 135 citations · Full text

Medicine, Immunology, Oncology +17

A Novel Method to Generate and Expand Clinical-Grade, Genetically Modified, Tumor-Infiltrating Lymphocytes

Marie-Andrée Forget, René J. Tavera, Cara Haymaker et al. · Frontiers in Immunology · 2017 · 55 citations · Full text

Life Sciences, Biotechnology, Immunology +17

Utilizing T-cell Activation Signals 1, 2, and 3 for Tumor-infiltrating Lymphocytes (TIL) Expansion: The Advantage Over the Sole Use of Interleukin-2 in Cutaneous and Uveal Melanoma

René J. Tavera, Marie‐Andrée Forget, Young Uk Kim et al. · Journal of Immunotherapy · 2018 · 48 citations

Life Sciences, Immunology, Oncology +17

Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot study

Yong Qin, Mariana Petaccia de Macêdo, Alexandre Reuben et al. · OncoImmunology · 2017 · 46 citations · Full text

Medicine, Immunology, Oncology +17

1–5 of 8